| Cas No.: | 78613-38-4 |
| Chemical Name: | Amorolfine hydrochloride |
| Synonyms: | Amorolfine Hydrochloride;AMOROLFINE HCL;Amorolfine HCI;Morpholine, 4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-, hydrochloride, (2R,6S)-rel-;Morpholine, 4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-, hydrochloride, cis-;(+/-)-cis-2,6-Dimethyl-4-[2-methyl-3-(p-tert-pentylphenyl)propyl]morpholine hydrochloride;(2R,6S)-rel-4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-morpholine, hydrochloride (1:1);Morpholine, 4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-, hydrochloride (1:1), (2R,6S)-rel-;002;Amorolfin;Ro 14-4767;(2R,6S)-rel-4-[3-[4-(1,1-Dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-morpholine hydrochloride;Ro 14-4767/002;Loceryl;Locetar;Curanail;Odenil;Amorolfine (hydrochloride);amorolfine hydrochloride;Amorolfine hydrochloride [JAN];Amorolfine hydrochloride, 98%;Amorolfine hydrochloride (JAN);Pekiron;Bekiron;Pekiron (TN);(2S,6R)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine hydrochloride;MLS006010200;Amorolfine Hydrochloride , 98% |
| SMILES: | Cl[H].O1[C@]([H])(C([H])([H])[H])C([H])([H])N(C([H])([H])[C@]1([H])C([H])([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C1C([H])=C([H])C(=C([H])C=1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])[H] |
| Formula: | C21H36ClNO |
| M.Wt: | 353.9696 |
| Purity: | >99% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Amorolfine hydrochloride is a antifungal reagent. |
| References: | [1]. Polak, A., Preclinical data and mode of action of amorolfine. Dermatology, 1992. 184 Suppl 1: p. 3-7. [2]. Richardson, M.D., G.S. Shankland, and C.A. Gray, Effect of amorolfine (Ro 14-4767/002) on in vitro phagocytosis and intracellular killing of Candida albicans by human neutrophils. Mycoses, 1989. 32(5): p. 245-9. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
| 2018-0101 |
|